HEPSERA

LOE Approaching

adefovir dipivoxil

NDAORALTABLETPriority Review
Approved
Sep 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT02327689Phase 4Unknown

Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients

Started Jan 2015
400 enrolled
Hepatitis B, ChronicFibrosis
NCT01436539Phase 4Unknown

Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

Started Sep 2011
300 enrolled
Chronic Hepatitis B
NCT01353742Phase 1Completed

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

Started Feb 2011
40 enrolled
Hepatitis B, Chronic
NCT00661076Phase 3Completed

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Started Aug 2008
10 enrolled
Hepatitis B, Chronic
NCT00531167Phase 4Completed

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

Started Apr 2007
219 enrolled
Chronic Hepatitis B